Immunotherapy agent benefits patients with drug-resistant multiple myeloma

27 agosto 2015

In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators report.
http://www.sciencedaily.com/releases/2015/08/150826204222.htm

Volver